Skip to main content
Canna~Fangled Abstracts

Use of cannabinoids for the treatment of patients with post-traumatic stress disorder

By March 4, 2021March 5th, 2021No Comments
Cannabinoids have been shown to be an effective treatment option for patients with PTSD.
Review
. 2021 Mar 4.

doi: 10.1515/jbcpp-2020-0279.

Online ahead of print.
Marika L Forsythe 1, Andrew J Boileau 1
Affiliations 

Abstract

Objectives: Post-traumatic Stress Disorder (PTSD) is a diagnosis of extreme anxiety caused by a traumatic event. Less than 10% of individuals who have experienced severe trauma will develop this disorder. Treatment options include various psychotherapies, but not all patients respond to them. Different pharmacological approaches have been explored as potential adjuvants, including using cannabinoids to target the endocannabinoid system to reduce the symptoms and enhance extinction training over the associated fear memories. This review was aimed to determine the effects of using cannabinoids for treatment of PTSD.

Content: For this review, four cohort studies, four randomized clinical trials, one case report, and one case series were obtained from PubMed within the last 10 years. Cannabis extracts, tetrahydrocannabinol (THC) and cannabidiol (CBD), and synthetic cannabinoids were used in the studies to target the cannabinoid receptors 1 and 2. Cannabinoids were shown to improve overall PTSD symptoms, including sleep quality and quantity, hyperarousal, and treatment-resistant nightmares. When participants were undergoing extinction training, cannabinoids given within the same time interval enhanced consolidation and retention.

Summary and outlook: Cannabinoids have been shown to be an effective treatment option for patients with PTSD. Besides aiding to relieve the symptoms and enhance extinction training, they also are relatively well tolerated. Common adverse effects included light-headedness, forgetfulness, dizziness, and headaches.

 

Keywords: PTSD, cannabidiol, cannabis, dronabinol, fear extinction, nabilone

References

    1. Hidalgo, RB, Davidson, JR. Posttraumatic stress disorder: epidemiology and health-related considerations. J Clin Psychiatr 2000;61(7 Suppl):5–13.
    1. Galea, S, Nandi, A, Vlahov, D. The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev 2005;27:78–91. https://doi.org/10.1093/epirev/mxi003.
    1. Herman, JL. Complex PTSD: a syndrome in survivors of prolonged and repeated trauma. J Trauma Stress 1992;5:377–91. https://doi.org/10.1002/jts.2490050305.
    1. North, CS, Suris, AM, Smith, RP, King, RV. The evolution of PTSD criteria across editions of DSM. Ann Clin Psychiatr 2016;28:197–208.
    1. Breslau, N. The epidemiology of trauma, PTSD, and other posttrauma disorders. Trauma Violence Abuse 2009;10:198–210. https://doi.org/10.1177/1524838009334448.

Publication types

Leave a Reply